Company
NextGen Jane
There’s power in the menstrualome
Also known as NextGen Jane, Inc
- Legal name
- NextGen Jane, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Jane is the only longitudinal molecular study of women’s menstruation on the planet. We are building a foundation of knowledge and transforming obstetric and gynecological health through molecular insight.
Funding snapshot
- Total raised
- $19.5MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $7M2023-09-20
Funding rounds
- Round, 2023
- $7M2023-09-20, SEC form D sold, 7 investors
- Round, 2022
- $1.5M2022-05-27, SEC form D sold, 2 investors
- Round, 2019
- $8.7M2019-03-19, SEC form D sold, 14 investors
- Round, 2016
- $2.2M2016-02-26, SEC form D sold, 7 investors
Loading relationship preview